Recent advances in the anti-HCV mechanisms of interferon

Interferon (IFN) in combination with ribavirin has been the standard of care (SOC) for chronic hepatitis C for the past few decades. Although the current SOC lacks the desired efficacy, and 4 new direct-acting antiviral agents have been recently approved, interferons are still likely to remain the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Menghao, Jiang, Jian-Dong, Peng, Zonggen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629091/
https://www.ncbi.nlm.nih.gov/pubmed/26579391
http://dx.doi.org/10.1016/j.apsb.2014.06.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629091/
https://www.ncbi.nlm.nih.gov/pubmed/26579391
http://dx.doi.org/10.1016/j.apsb.2014.06.010

Ejemplares similares